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Abstract
Seizure activity can be debilitating across a number of physical, social,
occupational, and personal domains.  Given the deficits in all of these areas frequently
present in persons with mental retardation, the control and elimination of seizures is a
primary goal for individuals with both mental retardation and epilepsy.  Antiepileptic
medication can reduce seizure activity. However, this intervention often carries with it
a range of untoward side effects that may adversely affect clients over what is
typically a long-term treatment regimen.  Over the last 20 years, literature has
emerged emphasizing the importance of environmental variables in the initiation and
maintenance of seizure activity. The assessment of such factors and subsequent
development of behavioral interventions to reduce seizure activity in persons with
mental retardation would be a significant addition to treatment efforts typically
dependent upon chemical intervention alone. The Matson and Mayville (M&M)
seizure scale is the first assessment tool designed to assess such factors specific to
persons with mental retardation.  This study examined the psychometric properties of
this scale through the assessment of internal consistency, construct validity, and inter-
rater, cross-rater, and test-retest reliability statistics.  Results revealed good inter-rater
reliability, but lower overall values for the remaining statistical evaluations.  Some
evidence of reliability and validity was apparent in individual items; further research
is needed to further evaluate the potential of this approach.  
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Introduction
Mental Retardation is a disorder that historically has received much attention
from scientists, mental health professionals, and policymakers.  Though it has been
recognized for centuries, mental retardation has been the subject of organized
assessment and treatment efforts only since the 1850's, the decade in which both the
first public and private institutions for persons with mental retardation were
established in the United States (Hodapp & Dykens, 1996).  Since this time, a variety
of approaches toward care of persons with mental retardation have appeared, ranging
in restrictiveness from total custodial care to normalized, least-restrictive models
(Wolfensberger, 1969).  While there has been considerable disagreement in the field
over a variety of treatment and assessment related issues, substantial progress has
been made in service provision for persons with this condition over the last 50 years. 
In addition to possessing a variety of social, communication, and occupational
deficits, persons with mental retardation often have a variety of physical disorders,
with the number and severity of physical problems covarying with the degree of
intellectual impairment.  Epilepsy is among the most common of these disorders, and
may present additional difficulties in a number of areas of functioning for the
individual with mental retardation.  Compounding these difficulties are medication
side effects of antiepileptic medications, the primary treatment approach for epilepsy
in all populations.  Thus, persons with both mental retardation and epilepsy may face 
additional challenges than the individual with either condition in isolation may not
experience.   
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Within the last 40 years, researchers have demonstrated that environmental,
psychological, and physical variables often interact in seizure genesis and
maintenance.  For example, large samples of individuals with epilepsy have reported
that seizures are often preceded by such conditions as tension, anxiety, and stress
(Antebi & Bird, 1993, Dahl, 1999), and that in some cases, individuals can induce
seizures for self-stimulatory or environmental manipulation purposes (Bruno-Golden
& Holmes, 1993, Dahl, 1992, 1999; Fenwick, 1994).  Following these findings have
been successful seizure reduction interventions which integrate psychological and
neurological models of seizure occurrence.  An integrated approach to epilepsy
treatment in persons with mental retardation is especially appealing, as behavioral
interventions are less reliant on medications that may interfere with functioning.  The
development of systematic assessment methods of psychological variables related to
seizures would be a significant step in establishing this approach as viable in persons
with mental retardation. 
The present study represents the first step in establishing such an assessment
measure.  The Matson and Mayville Seizure Scale (M&M) was created to measure
psychological and environmental factors related to seizures in persons with mental
retardation.  Establishing the reliability of the measure would be a significant first
step in developing a systematic, integrated assessment approach toward seizure





The definition of mental retardation has varied over time; early classifications
were made based on social competence, but more objective and intellectual criteria
evolved following the development of standardized intelligence tests in the early
1900's (Mathias & Nettlebeck, 1992).  For a number of years, substandard intellectual
functioning independent of adaptive functioning was considered in evaluation of
mental retardation (Scheerenberger, 1987).  However, in 1961 the American
Association on Mental Deficiency included in its definition of mental retardation the
component of associated impairment in adaptive behavior (Heber, 1961).  While
controversial, this concept became widely adopted following several elaborations on
this initial concept (see Grossman, 1973 & 1983; AAMR, 1992).  The current
definition as stated in the Diagnostic and Statistical Manual, Fourth Edition (DSM-
IV, American Psychiatric Association, 1994) is a combination of older and newer
AAMD definitions of mental retardation, and includes three criterion: (1)
Significantly subaverage intellectual functioning (IQ of 70 or below on standardized
intelligence test); (2) concurrent deficits or impairments in present adaptive
functioning; and (3) onset before the age of 18 years.  Critics of this definition have
maintained that the concept adaptive behavior is difficult to define and measure; thus,
classification should rely solely on substandard cognitive functioning, commonly
defined as two standard deviations below the mean on standardized intelligence tests
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(Zigler, Balla, & Hodapp, 1984).  Despite this criticism, the inclusion of adaptive
behavior in defining mental retardation remains standard practice in most circles. 
The DSM-IV classification system of severity of mental retardation indicates
an individuals degree of intellectual and adaptive impairment and contains four
hierarchical levels:  Mild (IQ scores of 50-55 to 70-75); Moderate (35-40 to 50-55);
Severe (20-25 to 35-40); Profound (20-25 or below), and Severity Unspecified (used
when there is strong presumption of mental retardation but the individuals
intelligence is untestable by current standard measures).  Features of adaptive
functioning typically exhibited at each severity level are outlined in the DSM-IV, but
specific measures of adaptive functioning, such as the Vineland Adaptive Behavior
Scales (Sparrow, Balla, & Cicchetti, 1984), yield standard severity scores that
correspond to the DSM-IV classification system.  When discrepancies occur between
the intellectual and adaptive scores, the diagnosis conferred corresponds to the higher
score. 
 Assessment of Intellectual Functioning
Assessment of intellectual functioning consists of performance on a
standardized intelligence test, the most popular of which are the Stanford-Binet
(Terman & Merrill, 1960; Thorndike, Hagan, & Sattler, 1986) and Wechsler scales
(Wechsler, 1989, 1991, 1997).  The Stanford-Binet L-M scale has traditionally been
considered a reliable and valid measure of intelligence and the instrument of choice
for screening individuals with mental retardation, but recent research indicates that
the Fourth Edition of the Stanford-Binet is also reliable and valid for this purpose
5
(Dacey, Nelson, & Stoeckel, 1999).  However, most standardized intelligence tests
fail to include adequate representation of mentally retarded persons in the normative
samples (Fuchs, Fuchs, Benowitz, & Barringer, 1987).
Assessment of Adaptive Functioning
The issue of formal assessment of adaptive functioning has been a contentious
one, as a variety of definitions of this construct have been proposed (Harrison, 1987;
McGrew & Bruininks, 1989; Widaman, Stacy, & Borthwick-Duffy, 1994).  The 1992
AAMR definition includes 10 areas of adaptive behavior: communication, self-care,
home living, social skills, community use, self-direction, health and safety, functional
academics, leisure, and work (AAMR, 1992).  However, it is unclear how areas such
as leisure, health and safety, and use of community resources are to be measured
(Gresham, MacMillan, & Siperstein, 1995; Hodapp & Dykens, 1996).  Nonetheless,
assessment of adaptive behavior is conducted in many applied settings using
standardized scales, the most popular of which are the Vineland Adaptive Behavior
Scales (Sparrow et al., 1984) and the AAMR Adaptive Behavior Scales (Nihira,
Foster, Shelhaas, & Leland, 1974).  Neither of these scales fully accommodate the
range of adaptive functioning domains as proposed by the AAMR, but both provide
valuable information useful in placement decision making and treatment planning.  
Seizures and Epilepsy
Definition and Classification
Seizures and epilepsy have been described in a variety of ways since
prehistoric times, and variation in definition persists today.  However, epilepsy is
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commonly viewed today as a disorder characterized by multiple seizures, with a
seizure representing abnormal paroxysmal cerebral discharge (Cull & Goldstein,
1997; Lennox, 1960; Gastaut, 1973; Trimble, Ring, & Schmitz, 2000).  Seizure
frequency specifications for epilepsy diagnosis have included at least two within a
two-year period (Cull & Goldstein, 1997), but as pointed out by Hopkins and
Appleton (1996), in practice, a diagnosis of epilepsy is frequently given if more than
one seizure of any type has been reported.   Hopkins and Appleton (1996) also
indicated that seizure definition should also involve awareness of the seizure to the
person experiencing it and/or to an observer, given that abnormal neuronal activity
may in and of itself not indicate what is commonly defined as a seizure. 
Additionally, they indicated that a continuing tendency for the individual to have
seizures should be acknowledged in a diagnosis of epilepsy, as more than one seizure
induced by traumatic events (e.g., nerve gas) would not be representative of what is
thought to be the disorder of epilepsy.  As can be ascertained from this rather modest
sample of definition issues, definitions of epilepsy have and continue to vary. 
Efforts have been made to classify both seizure types and epilepsy syndromes. 
Currently, the most widely accepted systems for seizure types is the International
Classification of Epileptic Seizures (ICES), while the system for epileptic syndromes
is the International Classification of Epilepsies and Epileptic Syndromes, both of
which were proposed by the International League Against Epilepsy (Dreyfuss, 1981;
ILAE, 1989).  In recognition of variation of definitions between epileptologists, these
systems were designed only as consensus agreement on epileptic syndromes, not as
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definitive statements.  Nonetheless, these systems are widely cited as the primary
seizure and epilepsy classification systems.  Because the focus of this paper is more
related to actual seizure behavior than type of epileptic syndrome, this paper will
focus on the description of seizure subtype.  However, a detailed discussion of all
seizure subtypes is beyond the scope of this paper; thus, the two primary types will be
covered generally, with references to and examples of subtypes falling within each
category. 
Classification of seizures as stated in the ICES is achieved through clinical
description without regard for seizure origin, with the primary distinction falling
between seizures that are generalized from onset and those that are partial or focal
and onset that may or may not lead to generalization.    
Generalized Seizures   
Generalized seizures are characterized by involvement of both cerebral
hemispheres in abnormal paroxysmal neuronal discharge at some point during seizure
activity (Trimble et al., 2000).  Such seizures are labeled as primary generalized if
both hemispheres are involved at seizure onset, and secondary generalized if the
involvement of both hemispheres is preceded by partial or focal activity (Holmes,
1997).  Tonic-clonic seizures are the most identifiable and easily diagnosed of the
generalized seizures, as they typically involve a loss of consciousness with a
simultaneous onset of generalized stiffening of the flexor or extensor muscles (tonic
phase), followed by generalized jerking of the muscles (clonic phase) (Holmes,
1997).  Absence seizures are also categorized as generalized, but may be more
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difficult to recognize and/or diagnose.  They are characterized by a sudden onset of
impaired consciousness and an accompanying blank facial appearance; clonic activity
(e.g., rapid eye blinking, jerking of the arms) automatisms (simple behaviors which
cannot be recalled, including rubbing the face or hands, licking lips, chewing), and
autonomic phenomenon (e.g., pupil dilation, flushing, sweating) may also be present
in complex absence seizures (Holmes, 1997).  Subtypes of absence seizures include
typical and atypical; typical absence seizures are often very brief, lasting only a few
seconds with abrupt termination, whereas atypical absence seizures last longer, may
be less abrupt in onset and/or cessation, and may result in more pronounced changes
in muscle tone (Hopkins & Appleton, 1996; Holmes, 1997).    
Other generalized seizures include clonic, tonic, myoclonic, and atonic.  As
their names would suggest, clonic and tonic seizures resemble the respective phases
of a tonic-clonic seizure in isolation.  Clonic seizures consist only of rhythmic or
semirhythmic contractions of a muscle group (Holmes, 1997).  These seizures are
also more common in children and involve primarily the muscles of the arms, neck,
and face.  Tonic seizures are characterized by brief period of sudden increased tone in
the extensor muscles which often result in a patient falling to the ground if he or she
is standing (Holmes, 1997).  Subtypes of tonic seizures include axial, axorhizomelic,
global, and asymmetric, each of which involve different body areas and different
behavioral patterns (Holmes, 1988, 1997).  Myoclonic seizures are more brief, shock-
like contractions that may involve the entire body, but more commonly are confined
to one muscle or group of muscles.  Frequently called myoclonic jerks, these
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seizures may accompany an absence seizure or precede a generalized tonic-clonic
episode (Holmes, 1997; Hopkins & Appleton, 1996).  Atonic seizures, also known as
drop attacks, involve a sudden loss of muscle tone which may lead to falling, and
are often accompanied by myoclonic jerks before, during, or after seizure activity
(Holmes, 1988, 1997). Atonic seizures are rare and usually occur in childhood
(Holmes, 1988).                
Partial Seizures
By definition, partial seizures involve abnormal neural activity that is
confined to one cerebral area; involvement of both cerebral hemispheres is not
present at seizure onset (Dreyfuss, 1981; Gastaut, 1970; ILAE, 1989; Trimble et al.,
2000).  Partial seizures (also called focal or local seizures, Dreyfuss, 1981) are
grouped into three categories: Simple partial, complex partial, and partial seizures
evolving to secondarily generalized seizures (generalized tonic-clonic, tonic, or
clonic).  Simple partial seizures are those in which there is no disturbance in
consciousness; subtypes include (1) with motor signs (e.g., Jacksonian, or a focal
motor seizure with spreading movement); (2) with somatosensory or special sensory
symptoms (e.g., visual, auditory, olfactory); (3) with autonomic symptoms or signs
(e.g., sweating, flushing, pupillary dilation); and (4) with psychic symptoms (e.g.,
dysphasia, cognitive, affective, illusions) (Drefuss, 1981).  Complex partial seizures
are those in which consciousness is disturbed to some degree; subtypes include (1)
simple partial onset followed by impairment of consciousness (with either simple
partial features or automatisms; and (2) with impairment of consciousness at onset
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(with either impaired consciousness only or with automatisms).  Finally, partial
seizures evolving to secondarily generalized seizures are typically seen in one of
three subtype forms: simple partial evolving to generalized, complex partial evolving
to generalized, and simple partial evolving to complex partial evolving to generalized
seizures (Drefuss, 1981). 
Psychogenic and Pseudoseizures
Pseudoseizures have been characterized as transient episodic seizures that are
not of an epileptic etiology (Gross, 1983).  That is, seizure genesis is attributed to
causes which may result from a number of psychological or medical factors not
related to an epileptic disorder, including psychosis, hyperventilation, photic
stimulation, fever, and drug withdrawal (Goldstein, 1997; Gross, 1983).  These types
of seizures present an obvious obstacle to pharmacologic treatment, thus this type of
intervention is often ineffective.  Seizures associated with psychological reactions,
particularly those labeled as hysterical, have also been called psychogenic, and
have primarily been viewed as a phenomenon outside the realm of epilepsy. 
However, this notion has recently been challenged by researchers who have
demonstrated that psychological factors often precede and may even induce seizures
in persons diagnosed with epilepsy (e.g., Dahl, 1999).  Recent surveys of large
samples of individuals with epilepsy have indicated that in many cases, seizure
incidence can be predicted by emotional or physical states, the most common of
which are anxiety, negative stress, fatigue, and tension (Antebi & Bird, 1993; Dahl,
1992, 1999; Loyning et al., 1993; Wolf, 1995).  These findings have lead some
11
researchers to conclude that because seizures are often preceded by psychological
factors, the majority of seizures could be classified as psychogenic regardless of
epileptic diagnosis (Dahl, 1999).  The distinction between psychogenic and epileptic
seizures is further blurred by an absence of underlying pathology in epilepsy in many
individuals with epileptic seizures (Ross, 1994).  
In line with these findings is the assertion of Fenwick (1994) that psychogenic
seizures stem from psychological factors but are no different from any other seizure
regarding abnormal brain activity.  He described two subtypes of psychogenic
seizures; those that are deliberately induced by the individual by a specific activity
(primary psychogenic) and those that are elicited by attending to a specific mental
task that accidentally stimulates an epileptogenic brain area (secondary psychogenic). 
Examples of primary psychogenic seizures include those that are self-induced by
photic stimulation (e.g., waving fingers in front of eyes rapidly in front of a light) and
hyperventilation; secondary psychogenic seizures would include seizures experienced
during such activities as reading (Forster, 1977) or playing card games (Striano, Meo,
Bilo, Soricellis, & Ruosi, 1993).  Overall, the definition of psychogenic or
pseudoseizures has varied since its inception, but in light of recent research, this term
may become less classifying and more descriptive of a variety of seizure types within
different contexts. 
Etiology
Models of the etiology of epilepsy have progressed from supernatural to
medical to bio-behavioral, with medical explanations accounting for the majority of
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documented approaches.  Hippocrates offered the first monograph on epilepsy in 400
B.C., in which he attacked popular superstitious beliefs of magicians and wizards
who regarded this disorder as divine and sacred (Lennox, 1960; Temkin, 1971). 
Hippocrates offered a more pragmatic and medical approach, stating that epilepsy,
like all diseases, was hereditary and a result of humoral pathology.  Several hundred
years later, Galen elaborated on this view and identified three different epilepsy types
based on etiology: 1) Idiopathic, caused by an imbalance of humors in the brain; 2)
Sympathetic, induced through the brains reaction to an irritating substance brought
to it from the body; and 3) the extension of a pathologic humor from an extremity to
the brain (Lennox, 1960).  The influence of Hippocrates and Galen was apparent in
the writings of physicians for several thousand years following and is detectible in
modern etiological theories.  However, supernatural explanations persisted and could
be found in formal writings as late as the 18th century (Lennox, 1960).            
Modern etiological classifications have developed from a medical concept and
resemble those outlined in Galens model.  The ICES has delineated epilepsies into
three etiological categories: idiopathic, symptomatic, and cryptogenic (ILAE, 1989). 
Idiopathic epilepsy is that which is not preceded by another physical condition or
disease (unknown cause), symptomatic epilepsy is considered a result of a known or
suspected central nervous system disorder, and cryptogenic epilepsy has a suspected
but unconfirmed etiology.  A multitude of potential causes for seizures exist;
however, etiology is unknown in approximately 50% of cases (Rothner, 1983). 
While seizures can occur at any age, they are most commonly first experienced
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before the age of 20, with cause correlating with type of epilepsy and age of onset
(Rothner, 1983).  In infants, genetic metabolic defects, anoxia, perinatal injury, and
congenital brain defects are among the most common (Lennox, 1960; Volpe, 1981),
while in children, brain infections, trauma, vascular disease, endocrine disorders, and
exposure to toxins have been cited as more common causes (Lennox, 1960; Rothner,
1983).  Head trauma is a common cause of seizures in young adults (Hopkins &
Appleton, Rothner, 1983), and tumors are suspected as the cause underlying first
seizures in persons over the age of 20 (Rothner, 1983).  In patients over the age of 50,
cerebrovascular disease (e.g., stroke) is the most common cause of seizures (Rothner,
1983).  Inheritance appears to be a factor in some types of epilepsy, but not to the
degree that was commonly believed up to approximately 40 years ago (Hopkins &
Appleton, 1996).  Where no abnormality of the brain or nervous system is found, a
genetic predisposition for epilepsy is often present (Rothner, 1983). 
A number of psychotropic and recreational drugs are known to be related to
seizure activity, either during normal use, abuse, or withdrawal (Hopkins &
Appleton, 1996).  Tricyclic antidepressants and phenothiazines are known for having
relatively low convulsive thresholds, while withdrawal from alcohol and barbiturate
medications may induce seizures (Hopkins & Appleton, 1996).  
Reflex epilepsy is a term used to describe a condition in which seizures have
been induced by some type of external sensory stimulation, the most common of
which is photic stimulation (Hopkins & Appleton, 1996).  This type of seizure is
believed to be induced when rhythmic flashes of light alter normal neuronal firing,
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and can be generated in a number of ways, including by hand (Fenwick, 1994), from
flickering light reflected from water (Hopkins & Appleton, 1996), and through
rapidly flashing lights from such sources as a strobe light or television (Hopkins &
Appleton, 1996; Takada, Aso, Watanabe, Okumura, Negoro, & Ishikawa, 1999).  A
few years ago, several hundred Japanese children were hospitalized for seizures
suffered while watching a popular cartoon that featured rapidly alternating flashing
red and blue lights (Takada et al., 1999).  In a sample of 95 of these children, Takada
and colleagues (1999) indicated that 43% had a confirmed abnormal EEG reading,
38% of whom had no history of epilepsy.                 
Prevalence and Incidence
Prevalence rates of epilepsy in persons with normal intelligence have ranged
from 1% (Cooper, 1965) to 3.5% (Trimble et al., 2000).  Incidence rates appear to be
age dependent; highest rates are found in early childhood, lowest rates are found in
early adulthood, and rates again increase in late adulthood, likely a result of increased
rates of cerebral vascular disease in this population (Rothner, 1983; Trimble et al.,
2000).  Currently, the overall risk for epilepsy appears to be slightly higher for males
than for females (Trimble et al., 2000).      
Neurobiology and Antiepileptic Medication
The neurotransmitters which have been most consistently implicated in
seizure activity are the inhibitory and excitatory amino acids, namely, gamma
aminobutyric acid (GABA), and aspartate and glutamate, respectively (Faingold,
1992; Trimble et al., 2000).  While both classes of neurotransmitters regulate
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neuronal firing, more attention has been given to the role of GABA, particularly
regarding the development of medications that alter GABA-ergic mechanisms
(Trimble et al., 2000).  Two classes of GABA receptors have been described, GABAa
and GABAb; the GABAa receptor has been implicated in CNS neuronal inhibition and
has therefore been the subject of much investigation for its role in seizure activity
(Trimble et al, 2000).  Newer models of epilepsy have hypothesized that an
interaction between glutamate receptors and calcium is important in seizure initiation,
but the precise relationship between this interaction and seizure activity is currently
speculative (Trimble et al., 2000).    
Many antiepileptic medications have been either found or hypothesized to
operate on GABA, either by potentiating the inhibitory effect of GABA on neuronal
firing or by mimicking the action of this neurotransmitter (Alvarez, Besag, &
Iivanainen, 1998; Trimble et al., 2000).  However, other mechanisms of neuronal cell
activities are affected through some antiepileptic medications as well; for example,
the medications lamotrigine, phenytoin, valproate, and carbamazepine appear to
block voltage-gated sodium channels to inhibit repetitive neuronal firing, though their
precise antiepileptic actions are unknown (Alvarez et al., 1998).  Additionally,
medications may act on NMDA-type glutamate receptors to decrease glutamate-
mediated exitotoxicity (e.g., felbamate).  Whatever their pharmacodynamics,
antiepileptic medications all have potentially adverse side-effects which range from
nuisance value to life-threatening.  A more detailed discussion of these effects is
presented in the following section.     
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Epilepsy and Mental Retardation
Given the multitude of complicating factors that accompany both epilepsy and
mental retardation, persons affected by both conditions are faced with additional
hardship than those having either condition in isolation.  Potential interruption in
learning, social, and occupational opportunities precipitated by seizure activity is
compounded by deleterious side effects frequently induced by antiepileptic
medications (Alvarez et al., 1998; Alvarez, Kern, Cain, Coulter, Iivanainen, &
Plummer, 1998).  Assessment of specific negative effects of epilepsy on quality of
life in persons with mental retardation is complicated by interpretation of this
concept as it applies to this population.  Nonetheless, studies investigating the
prevalence of social and psychological problems in persons with both mental
retardation and epilepsy have revealed that the combination of these two conditions is
associated with a shorter life span (Hanson, Nord, & Weiseler, 1997), deficits in
social skills (Hoare, 1984; Matson, Bamburg, Mayville, & Kahn, 1999), and deficits
in adaptive behavior (Matson et al., 1999).  Increased rates of psychopathology have
also been cited as a frequently occurring comorbid condition ( e.g., Cadman, Boyle,
Szatmari, & Offord, 1987), with assessment becoming more difficult to assess as
intellectual functioning declines (Matson et al., 1999).  Thus, it can be stated that
epilepsy is likely to further complicate the general well-being and quality of life for
persons with mental retardation.  
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Prevalence
It is well established that epilepsy is more prevalent in persons with mental
retardation than in the general population, with prevalence increasing as intellectual
functioning decreases (Bird, 1997).  The majority of the research supporting these
findings has involved children, and have reported rates higher than those found in
adults.  In a study of 378 children with mental retardation aged 6 to 13, Steffenburg,
Hagberg, and Kylerman (1996) found that 15% of the sample with mild retardation
also were diagnosed with epilepsy, compared to 45% of the sample with severe and
profound retardation.  Similarly, in a sample of 643 children in Sheffield, England,
Shepard and Hosking (1989) found that 7% of participants with mild retardation also
had been diagnosed with epilepsy, whereas 67% of participants with severe and
profound retardation had been so diagnosed.  Prevalence studies with adults have
revealed rates between 14% and 41% (Deb, 1997; Deb & Joyce, 1999a; McGrother,
Hauck, Bhaumik, Thorp, & Taub, 1996), with a higher proportion of individuals
residing in institutional settings having epilepsy.  Taken together, prevalence studies
indicate that between 5% and 50% of persons with mild and moderate impairment
have epilepsy, and between 26% and 67% for persons with severe and profound
impairment have this condition (Blomquist, Gustavson, & Holmgren, 1981; Coulter,
1983; Rutter, Tizard, Yule, Graham, & Whitmore, 1976; Deb, 1997; Goulden,
Shinnar, Koller, Katz, & Richardson, 1991; Hollingsworth, 1978; McGrother et al.,
1996; Nevo et al., 1995; Richardson, Koller, Katz, & McLaren, 1980; Shepard and
Hosking, 1989).  These rates are far greater than the rate of 1% - 3.5% found in
populations of persons with normal intelligence (Cooper, 1965; Trimble et al., 2000).  
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          The presence of comorbid physical and/or neurological impairment,
particularly cerebral palsy, is an important variable affecting prevalence of epilepsy
in persons with mental retardation.  Benedetti and colleagues (1986) found in an
American sample of persons with mental retardation and cerebral palsy a rate of
epilepsy of 50%, compared to 10% of participants with mental retardation only. 
Similarly, Goulden and colleagues (1991) found rates of epilepsy in children with
mental retardation and cerebral palsy varying from 28% to 39%, compared to 2.6%-
5.2% in persons without mental retardation.  In a study of the evolution of epilepsy in
78 children with mental retardation, Eriksson, Erila, Kivimaki, and Koivikko (1998)
found that cerebral palsy was the single most important risk factor for severe
epilepsy.  Additionally, as observed by Eriksson and colleagues (1998) persons with
mental retardation and cerebral palsy who have epilepsy tend to display a common set
of characteristics, including a high initial seizure frequency, early onset of seizures
and multiple types, an increase in drug resistance, lower long-term remission rates,
and a higher seizure recurrence rate following anticonvulsant medication
discontinuance.  Overall, cerebral palsy appears to be a significant contributing factor
of the presence of epilepsy in this population, with rates ranging from 28% to 94%,
significantly higher than when CP is not present (Benedetti, Shinnar, Cohen, Inbar, &
Hauser, 1986; Corbett, 1985; Shepherd & Hosking, 1989).
Etiology of mental retardation is another factor affecting prevalence rates of
epilepsy in persons with mental retardation.  The prevalence of epilepsy in persons
with Down syndrome, a genetic condition invariably resulting in mental retardation,
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has been estimated from 5% to 10% (McVicker, Shanks, & McClelland, 1994;
Pueschel, Louis, & McKnight, 1990; Strafstorm, 1999).  As is the case with
individuals with mental retardation not due to Downs syndrome, prevalence rates
rise as age increases; however, this effect is usually more dramatic in persons with
Downs syndrome.  In a sample of 191 adults with this condition, McVicker and
colleagues (1994) found an overall 9.4% prevalence rate of epilepsy across ages, but
the rate jumped to 46% in individuals over 50.  For individuals in this sample
diagnosed with Alzheimers disease, the rate increased to 80%.  In a survey of 405
Downs syndrome patients, Pueschel and colleagues (1990) also found a relationship
between increasing age and epilepsy (40% in participants over 30), but also found
that 40% of participants displaying seizures did so before one year of age.  Thus, it
appears that epilepsy becomes increasingly prevalent with age for persons with Down
syndrome, and in many individuals may present very early in life.  Several more rare
etiologies of mental retardation are also related to high prevalence rates of epilepsy,
including 75% in Rett syndrome, 86% with Angelman syndrome, 50% with Lesch-
Nyan syndrome, and 30% with Lowe syndrome (Deb, 2000).     
Etiology
Causes of epilepsy in persons with mental retardation encompass the same
range of factors previously discussed in persons with normal intellectual functioning.  
In many cases, the etiology of epilepsy in persons with mental retardation is related to
the cause of the retardation itself.  Both conditions are associated with metabolic
disorders (e.g., phenyketonuria, Tay-Sachs disease), dysplastic conditions (e.g.,
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tuberous sclerosis, Sturge-Weber syndrome), prenatal infections (e.g.,
cytomegalovirus, syphilis, toxoplasmosis), and postnatal infections (e.g., purulent
meningitis, acute encephalitis) (Bird, 1997).  Lennox-Gastaut syndrome, an epileptic
syndrome characterized by atonic, tonic, and/or myoclonic seizures presenting prior
to three years of age, is an example of an epileptic syndrome in which mental
retardation is invariably associated (Deb, 2000; Hopkins & Appleton, 1996). 
However, in many cases, specific etiology of both epilepsy and mental retardation is
unknown, and any relationship between the two conditions can only be speculated
(Alvarez et al., 1998).                  
As previously mentioned, increased seizure frequency in persons with Downs
syndrome  has been observed, and several hypotheses for this relationship have
surfaced.  Recently, the gene for Unverricht-Lundborg disease (a rare form of
myoclonic epilepsy) was discovered at the distal long arm of chromosome 21, within
the critical Downs syndrome region (Bird, 1997; Stafstorm, 1999).  Additionally, a
gene for glutamate receptor GluR5, thought to be involved in neuronal excitability,
was discovered in the same region (Stafstorm, 1999).  While the precise relationship
between these findings and epilepsy in persons with Downs syndrome is currently
unknown, it appears that a genetic contribution to epilepsy may exist in this case. 
The onset of Alzheimers disease also appears to be an important etiological factor in
persons with Downs syndrome, as 80% of patients with this condition have been
observed to present with seizures following the onset of Alzheimers (McVicker et
al., 1994).       
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Antiepileptic Medication Treatment
As in persons with normal intelligence, medication has historically been the
first-line of treatment for epilepsy in persons with mental retardation.  However,
epilepsy in this population is often particularly difficult to treat for several reasons,
including the presence of several different seizure types concurrently, the presence of
significant brain abnormality or dysfunction, initial resistance to antiepileptic
medication, and early onset of epilepsy (Alvarez et al., 1998a).  As such, practices of
antiepileptic medication use in this population often involve methods avoided in non-
mentally retarded populations, including excessive use and polypharmacy medication
regimens (Alvarez et al., 1998a, Deb & Joyce, 1999b).  Deb and Joyce (1999b)
surveyed antiepileptic medication use in a sample of 143 adults with mental
retardation in Wales, and found that 42% were receiving polytherapy.  Of this
percentage, 28%, 12.6%, and 1.4% were taking 2, 3, or 4 antiepileptic medications
concurrently.  However, awareness of special considerations needed for antiepileptic
medication treatment in this population is rising, primarily as a result of research
demonstrating the susceptibility of these individuals to deleterious medication effects
that may or may not be apparent (e.g., Alvarez et al, 1998a; Burd, Kerbeshian, &
Fisher, 1987; Espie, Gillies, & Montgomery, 1990; Fischbacher, 1982; Gay, 1984;
Hanzel, Bauernfeind, Kalachnik, & Harder, 2000; Mayhew, Hanzel, Ferron,
Kalachnik, & Harder, 1992).  As will be discussed below, antiepileptic medication
side effects are not uncommon and can lead to serious impairment in a number of
areas particularly relevant to persons with mental retardation, such as learning and
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social and occupational functioning (see Alvarez et al., 1998a and 1998b, for
reviews).  Antiepileptic medication can successfully prevent seizure activity in
persons with mental retardation likely to manifest such behavior (Alvarez et al.,
1998b).  Optimal response is dependent upon a number of factors, most of which are
relevant in non-mentally retarded populations.  Obtaining an accurate seizure
diagnosis is important in determining the most efficacious medication to be used, but
this may be an especially difficult task in persons with mental retardation.  A
combination of electroencephalogram (EEG) investigation, behavioral observation,
and detailed history information is needed to make as certain a diagnosis as possible
(Bird, 1997).  Obtaining all, or even some of this information may not be possible,
thus placing the diagnostic burden more on behavioral observation from carers.  This
situation may result in mislabeling conditions that may appear seizure-like as actual
seizures, including motor tics, stereotypies, various movement disorders, and atypical
presentations of psychiatric disorders (Bird, 1997).  The resulting ineffectiveness of
the antiepileptic medication may result in higher than average doses and/or
administration of multiple medications.
Barbiturates
Phenobarbital, the most familiar of the barbiturates, has been used as an
antiepileptic in persons with mental retardation since its introduction in 1912
(Alvarez, 1998).  The well-documented behavioral and neurocognitive side-effects of
this medication are especially concerning when used in this population, given the
deficits in cognitive ability and behavioral problems often present in these
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individuals, and the subsequent pharmacological treatment of problem behavior
induced by phenobarbital use (Hanzel, Kalachnik, & Harder, 1992; Hanzel et al
2000).  Phenobarbital use in persons with mental retardation has been associated with
depression (Trimble & Corbett, 1990), lowered frustration tolerance (Gay, 1984),
hyperactivity (Burd, et al., 1987) conduct disorder (Trimble & Corbett, 1990), and
exacerbation of pre-existing hyperactive and aggressive behavior (Ingram, 1986). 
Though often effective in controlling epilepsy, barbiturate medications are becoming
less frequently used following the advent of newer anticonvulsants less likely to
induce such adverse effects.   
Several studies have cited improvements in behavior and/or cognition when
phenobarbital is subtracted from a polypharmacy regimen, with the majority of
subjects not exhibiting increased seizure frequency (Hanzel et al., 2000; Mirza,
Credeur, & Penry, 1993; Poindexter, Berglund, & Kolstoe, 1993).  However, the
degree of benefits following discontinuation are debatable given the subjective nature
of the data in these studies (retrospective chart review, anecdotal report), as well as
several studies citing no improvement in cognition or behavior following removal of
phenobarbital from an antiepileptic medication regimen (Alvarez & Hazlett, 1983;
Coulter, 1988).  Thus, more research is needed to elucidate specific benefits of
phenobarbital discontinuation in persons with mental retardation.                
           Phenytoin
Phenytoin has a long history of use in persons with mental retardation, and its
popularity continues due to its efficacy in controlling seizure activity and its low cost
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(Iivanainen, 1998).  The adverse side effects of phenytoin are numerous and wide-
ranging, and present special problems to individuals with mental and physical
complications.  Perhaps most troubling are the adverse neurological effects, which
often are irreversible (Iivanainen 1998).  Deterioration of intellectual and cognitive
functioning, drowsiness, truncal or limb ataxia, progressive motor coordination
complications, and loss of locomotion have all been documented, all of which may be
especially menacing to persons with mental retardation (Iivanainen, 1998).  Few
studies exist evaluating the side effects of this medication in this population;
however, it does appear that certain mentally retarded individuals may be more
adversely affected by specific phenytoin side effects than individuals with normal
intelligence.  In a sample of 131 patients with mental retardation taking phenytoin,
Iiavanainen Viukari, and Helle (1977) found a 28% rate cerebellular atrophy
secondary to phenytoin toxicity, with 23.5% of the sample displaying a persistent loss
of locomotion. 
Valproate
Valproate has become a primary medication for treatment of epilepsy in
persons with mental retardation (Espie et al., 1990), and is an especially attractive
choice given its more acceptable tolerability profile and ability to reduce multiple
seizure types (Friis, 1998).  West syndrome and Lennox-Gastaut syndrome,
conditions associated with infantile spasms and childhood seizures of multiple types,
respectively, as well as mental retardation, have both been found to be responsive to
valproate with few adverse effects reported (Covanis, Gupta, & Jeavons, 1982;
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Simes, Spohr, Michael, & Nau, 1988).  However, hepatotoxicity associated with
valproate treatment, though rare, is potentially fatal and can be more likely to occur in
persons with mental retardation (Friis, 1998).  Additionally, coagulation problems
and subsequent hemorrhaging or easy bruising may occur, a factor which may
exclude patients with self-injurious behavior from valproate treatment (Alvarez et al.,
1998).                 
Carbamazepine
Due to its minimal untoward effects on cognition and behavior, low toxicity,
and antiepileptic efficacy, carbamazepine is widely used in persons with mental
retardation (Alvarez et al., 1998; Waisburg & Alvarez, 1998).  In an investigation of
carbamazepine-induced hyponatremia in persons with mental retardation, Kastner,
Friedman, and Pond (1992) found a 5% rate of this problem in a sample of 40
patients, with only one of these individuals displaying clinically significant
symptoms.  Adverse behavioral side-effects have been documented in this population,
but reports are few and are have been limited to exacerbation of preexisting behavior
problem in patients taking carbamazepine for behavioral or psychiatric reasons
(Friedman, Kastner, Plummer, Ruiz, & Henning, 1992).  While neurotoxicity can
occur, it tends to be dose-related and reversed with a decrease in dosage (Waisburg &
Alvarez, 1998).  
Benzodiazepines
Benzodiazepines may be effective as adjunct medications in addressing
treatment-refractory epilepsy and in emergency cases (e.g., status epilepticus), thus
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making them useful in persons with mental retardation for whom such conditions are
common (Iisojärvi & Tokola, 1998).  Indeed, these individuals require emergency
benzodiazepine treatment more frequently than individuals with normal intelligence
(Iisojärvi & Tokola, 1998).  In such cases, rectal administration of diazepam is
common; this medication has fewer and more mild adverse effects, and this method
of administration is practical and appears more efficacious than other methods
(Iisojärvi & Tokola, 1998).  Aside from adjunctive roles and emergency situations,
benzodiazepines are not commonly used as first-line agents and/or as monotherapy
due to the potential problems with these medications listed earlier in this paper.       
Other Antiepileptics
A number of newer antiepileptic medications have surfaced within the last 20
years which have been reported to be efficacious and have fewer adverse effects (e.g.,
gabapentin, lamotrigine, tigabine, zonisamide, toprimate, vigabatrin, oxcarbazepine). 
This development is an acknowledgment by pharmaceutical companies that earlier
medications produced unacceptable side effect profiles and were not always effective. 
However, as noted by Alvarez and colleagues (1998b), there are relatively few data
available for these medications and any conclusions about them must be interpreted
cautiously.  Several studies including participants with developmental disability have
been conducted with gabapentin, oxcarbazepine, and vigabatrin all of which reported
good antiepileptic efficacy and few side effects (Bhaumik, Branford, Duggirala, &
Ismail, 1997; Gaily, Granström, & Liukkonen, 1998; Mikati, Coueri, Khurana,
Riviello, Helmers, & Holmes, 1998; Provinciali, Bartolini, Mari, Del Pesce, &
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Ceravolo, 1996; Ylinen, 1998), though reversible hyperactivity and disruptive
behavior have been reported for gabapentin use in children with mental retardation
(Mikati et al., 1998).  Conflicting findings have been reported for lamotrigine, with
studies reporting both increases and decreases in seizures, and both negative and
positive behavioral outcomes (see Besag, 1998, for a review).  Overall, the newer
antiepileptic medications have promise as safe and effective antepileptic agents, but
more research is needed to clarify this.     
Behavioral Treatment of Epilepsy
Thus far, the treatment of epilepsy has been described from a medical
standpoint.  Indeed, medication intervention is the most common form of treatment
currently employed, and is fueled by a medical concept of this condition.  However,
over the past 50 years, the notion that seizures result from an interaction of biological
and environmental events has received increased attention in scientific literature,
culminating in calls by some authors for a complete paradigm shift in epilepsy
assessment and treatment (e.g., Dahl, 1999).  Current efforts to proliferate a
behavioral medicine approach to epilepsy are currently focused primarily outside of
the realm of mental retardation, but a groundwork within the area of mental
retardation has been established upon which further efforts can be built.    
History
Galen was perhaps the first physician to describe how procedures affecting
sensation and perception could influence seizure activity.  As discussed in Temkin
(1971), Galen identified several different types of epilepsy, one of which originated
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outside of the brain in an extremity and progressed through the body.  Galen believed
that treatment of this type of seizure could be best approached through an external
intervention applied when the patient felt the initial sensation in the extremity,
described as a breeze (p. 63) passing through the patients body.  This concept
extended from the theory that pathology was caused by humoral imbalances; in this
case, Galen viewed epilepsy as a combination of cold humors (phlegmatic,
melancholic), and the breeze was the beginning of the movement of these humors. 
When this sensation was identified, treatment was aimed at physically restricting the
flow of the humors to prevent the seizure that would likely follow.  This treatment
was likened to treating a bite of a poisonous animal or insect, and was claimed to be
successful by Galen and a number of sixth and seventh century A.D. physicians. 
Galen was essentially the first to identify auras as they are now called, the
phenomena that would become the center of more sophisticated behaviorally-based
interventions for epilepsy centuries later.
During the late 1800's, several reports surfaced detailing the avoidance of
seizure activity based on intervention with sensory stimuli following the onset of an
aura (Gowers; Brown-Sequard, as cited in Dahl, 1992).  More detailed accounts
appeared in the 1940's and 50's; a convincing study by Efron (1957) displayed how
seizures could be inhibited by the presentation of olfactory stimuli and as well as
secondary conditioned stimuli presented with these stimuli.  Similarly, Forster (1977)
conducted a series of studies in the 1960's that investigated different variables in this
conditioning process, and found that conditioning could not only influence which
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stimuli could evoke or suppress a seizure, but that an individuals sensitivity to
seizure-eliciting stimuli could also be altered.  Specifically, he found that increased
exposure to these stimuli at a given threshold could essentially have a desensitizing
effect, and would subsequently result in reduced seizure frequency.  These findings
had obvious treatment implications, and indeed, participants in these studies learned
to tolerate specific seizure-inducing stimuli and enjoyed a reduced number of seizures
beyond their experimental involvement.  However, medical treatment (i.e.,
medication) was still viewed as the only viable approach to epilepsy treatment
(Forster, 1977).
Seizure Reduction Using Contingency Management
Based on contingency management and behavioral chain interruption, a
number of researchers began applying operant behavioral principles to treating
children and mentally retarded adults with epilepsy.  Using differential reinforcement
in a reversal design, Gardner (1967) eliminated seizures serving a behavioral function
in a 10-year-old girl.  Treatment involved altering reinforcement contingencies so that
the child received parental attention for appropriate behaviors but not for seizures.
The intervention resulted in rapid and complete cessation of seizure behavior, and the
functional relationship between seizure behavior and parental attention was
demonstrated in a 26-week follow-up.  During the first reversal phase, parental
attention was again given for seizure behavior and the child again manifested seizure
behavior.  Seizure behavior again extinguished when parental attention was again
purposely withdrawn for this behavior. 
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Zlutnick, Mayville, and Moffat (1975) demonstrated how the interruption of
antecedent behavioral chains could inhibit seizure activity of varying types. 
Participants were five children diagnosed with varying degrees of mental retardation
and several other related problems (e.g., autism, learning disability) as well as
absence, minor motor and/or major motor seizures.  Each participant was found
to exhibit one or more discrete behaviors just prior to the onset of seizure activity. 
Using an ABAB design for each participant, seizure frequency was reduced
significantly in four of five cases utilizing such techniques as interruption (e.g.,
firmly grasping the individual and firmly stating No!) and differential
reinforcement (e.g., effusive verbal praise, receipt of an M&M candy following
successful redirection) and was maintained at six-month follow-up.  Iwata and
Lorentzson (1976) also employed an ABAB design to evaluate a behavioral program
consisting of increased daily activities, differential reinforcement of other behavior,
and time-out in an effort to reduce the long-standing seizure behavior in a mentally
retarded 41-yr-old male.  A marked decrease in seizure activity was found during the
treatment.  Gradual fading of activities and DRO was implemented at the 10-week
mark, and the decrease in seizure activity was maintained.
By the early 1980's, approximately 11 studies utilizing contingency
management in modifying seizure activity had been conducted, the majority of which
reported consistent and lasting reductions in seizure frequency (Kraft & Poling,
1982).  However, as reviewed by Kraft and Polling (1982), the majority of these
studies had methodological weaknesses that precluded meaningful interpretation of
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the impact of behavioral techniques in these instances.  Among these weaknesses
were inadequate experimental design, failure to adequately quantify dependent
variables, use of non-blind raters, infrequent interobserver agreement, and inadequate
explanation of treatment procedures.  Only two studies (Iwata & Lorentzson, 1976;
Zlutnick et al., 1975) employed rigorous methodological designs and explicitly
described procedures, and only one of these two provided follow-up (Zlutnick et al.,
1975).  Thus, the initial excitement of the utilization of behavioral interventions to
treat epilepsy was tempered by the need for additional scientifically rigorous studies. 
Unfortunately, within the population of persons with mental retardation, little
progress has been made beyond this point.         
Neurological Models Underlying Behavioral Interventions      
Despite the burgeoning literature of behavioral intervention for seizure
activity, the neurological underpinnings of the mechanism of action in such an
approach had received little attention.  Based on their series of experiments with
primates, Lockard and Ward (1980) introduced such a neurological model describing
the mechanism by which conditioned avoidance of focal seizure activity operated. 
Focal epileptogenic lesions were made in the brains of monkeys and electrodes were
then planted in these areas.  From this procedure, two groups of damaged neurons
were identified: group one" consisted of partially damaged neurons in the center of
the damaged area that always fired in a continuous epileptic mode.  These neurons
were viewed as the generators of the epileptic seizures.  Group two" neurons
surrounded group one and were partially damaged; however, these neurons did not
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always fire in a dysfunctional fashion and could be influenced by external brain
activity.  This model held that in an epileptic seizure, interaction of both groups was
necessary for seizure occurrence.  In their research with primates, the authors
demonstrated how the initiation of a seizure depended upon how the primates
responded to early seizure signals.  Activity of damaged focal neurons was necessary
but not sufficient to initiate an epileptic seizure.  As such, a group of primates with
identical brain damage would not all display epileptic seizures.  Thus, in this model a
connection between external stimuli and the seizure genesis area in the brain existed,
providing a window through which seizure activity could be manipulated. 
While a direct study of this model has not been conducted with human
subjects, Fenwick and Brown (1989) described the relevancy of this model to humans
through the description of several case studies, all of whom learned to successfully
control seizures through recognition of seizure cues and subsequent employment of
behavioral seizure-reduction procedures.  Unfortunately, all of these reports consisted
solely of clinical description and did not employ experimental methodology in
evaluation of this model.  However, their results echo those yielded from more
controlled efforts (e.g., Iwata & Lorentzson, 1976; Zlutnick et al., 1975) in that
inducing a change in pre-seizure behavior can inhibit subsequent seizure activity of
varying types.  The neurological explanation for this phenomenon offered by Lockard
and Ward (1980), while currently untested through EEG data in humans, is a
promising model for future behavioral investigations of human seizure activity. 
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Psychological Factors in Seizure Initiation
Since the development of the Lockard and Ward model, researchers have
investigated the role of awareness and psychological states in seizure evocation.  The
majority of the research in this area has come from self-reports regarding sensations,
feelings, and psychological states before and after a seizure, though some studies
have also incorporated caregiver and direct observation.  In a survey of 160 adults
and children with simple and partial complex seizures, Dahl (1992, 1999) reported
that 100% of individuals experiencing simple-partial seizures could identify the
beginning of a seizure through physical sensation.  Additionally, a large percentage of
the sample could predict seizure onset based on the experience of specific emotions. 
Among the most common antecedent conditions were drowsiness (83.65%),
immediately following physical activity (83.02%), negative stress (77.85%), muscle
tension (71.07%), panic (64.15%) conflict with others (59.12%), and just prior to
physical activity (52.20%).  The lowest-risk conditions reported included even and
optimally stimulated (93.08%), on vacation (85.00%), even relaxed state
(75.47%), feels happy (65.82%), and no demands (63.08%).  Thus, participants
and their caregivers felt that they were able to identify numerous conditions under
which a seizure was more or less likely to occur.  
Antebi and Bird (1993) also surveyed 100 persons experiencing a range of
epileptic seizure types regarding factors most likely to facilitate or inhibit seizures. 
Tension and anxiety, unhappiness/depression, overexcitement, and anger were among
the most frequently endorsed emotional states that participants felt increased the
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frequency of their seizures.  Factors that participants felt decreased the likelihood of
seizure occurrence included feeling happy and relaxed.  A number of states that were
endorsed almost equally as likely to inhibit or precipitate seizures included boredom,
sexual arousal, and most notably, tiredness (35% felt that this state inhibits and 35%
felt it precipitates).  Caregivers or family members of the respondents were also
surveyed, with 80% reporting that they felt they could identify seizure facilitating or
inhibiting conditions in their patient or family member.  Of the conditions that were
identified, stress/ worry/anxiety, tiredness/overtiredness, and anger were the most
commonly cited antecedents at  54%, 15%, 9%, endorsement, respectively.  Both
tiredness and stress have also been reported as a seizure antecedent in several other
studies (Friis & Lund, 1974; Gunderson, Dunne, & Feyer, 1973; Wolf, 1995).  While
Antebi and Bird used an unvalidated, semi-structured interview, these results taken
together with those of Dahl (1999) and other reports suggest that persons with
epilepsy and their caregivers may be able to identify situations and/or stimuli likely to
affect seizures.
Induced Seizures
As previously discussed, epileptic seizures can be induced by certain types of
stimulation, whether generated externally (e.g., flashing lights on TV) or by the
patient themselves (e.g., hyperventilation).  Fenwick (1994) described several case
reports of patients inducing seizures, one of whom could induce absence attacks by
rapidly shifting his attention following scoldings from his mother, and another who
could induce grand-mal seizures by lying on his bed and deliberately holding his
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mind empty and blank for several minutes (p. 180).  Prevalence rates of self-induced
seizures have ranged from 5% to 25% (Fenwick, 1981; Finkler, Lozar, & Fenwick,
1990; Symonds, 1959), with several reports indicating that approximately 2-5% of
patients with epilepsy inducing seizures using photic stimulation, the most commonly
cited method of seizure induction (Kastelejin-Nolst Trenité, 1989).  Researchers have
suggested that persons with mental retardation may be more likely to engage in
stereotyped behavior leading to photosensitive seizures (Espie & Paul, 1997), but
reliable prevalence data supporting this statement is lacking.  Eliciting seizures at will
through hyperventilation has been reported in adults with epilepsy (Fabisch &
Darbyshire, 1965), and is one of the most common methods by which children induce
absence seizures (Holmes, McKeever, & Adamson, 1987).  Hyperventilation induced
grand-mal seizures were also reported in two children with profound mental
retardation, and behavioral intervention for reduction of seizure frequency and
severity was reported to be effective (Bruno-Golden & Holmes, 1993).
As with any behavior, consequences of seizures can act to make seizures more
likely to occur in the future, especially with those that have been purposefully
induced by the individual experiencing them.  Dahl (1999) found that 68% of 160
children and adults with epilepsy wished to retain a certain frequency of seizures, as
assessed by self and third party report.  The most commonly assessed consequences
included self-stimulation, avoidance of demands, and access to desired items or
special privileges.  Patients in this sample classified as having some degree as mental
impairment were thought to enjoy self-stimulatory properties of seizures and
avoidance of demands consequences more frequently than those without mental
impairment.                           
36
 Assessment of Psychological and Environmental Factors
The assessment of psychological and environmental factors related to seizure
initiation and maintenance is a developing area, though this concept is not new as
demonstrated earlier in this paper.  Direct observation and third-party report have
been the most commonly used methods in studies utilizing experimental
manipulation.  However, data reliability in many studies is questionable, with few
attempts made to formally address this issue (Kraft & Poling, 1982).  More recent
efforts have utilized questionnaires in which patients and/or caregivers answer
structured or semi-structured questions (e.g., Antebi & Bird, 1993; Dahl, 1992). 
However, analyses of the psychometric properties of these instruments has not been
assessed.
The development of systematic methodology to assess the underlying
motivation for problem behavior (functional assessment) has been an important
development in the assessment and treatment of problem behavior (see Harris,
Delmolino, & Glasberg, 1997, and Sturmey, 1996, for reviews).  Dahl (1992) has
offered the most comprehensive and detailed assessment battery for conducting a
behavioral assessment of seizure occurrence in children.  Her protocol consists of
structured and semi-structured interviews for both the child and parents, behavioral
observation procedures (antecedent-behavior-consequence assessment,
comprehensive seizure logs), and explanation of how EEG data is interpreted and
how it can be integrated with behavioral assessment results.  Detailed information is
provided for assessment of factors relevant to a thorough behavioral analysis,
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including auras, eliciting stimuli, emotional states, high and low risk seizure
situations, pre and post ictal activity, interictal activity, and lower demand
expectations.  While no formal reports of validity and reliability have been published
for this battery, an outline for how reliability and validity of data can be assessed is
provided.  
Feasibility of Behavioral Treatment as Monotherapy
Despite the considerable literature documenting the significant role of non-
medical factors in seizure initiation and maintenance, the traditional medical concept
of epilepsy continues to guide treatment almost exclusively.  Currently, little room
exists for integration of  behavioral interventions into a mainstream treatment
approach.  While it is doubtful that a behavioral approach would be sufficient to
consistently address all types of epilepsy, evidence is surfacing suggesting that non-
medical treatment may be efficacious in isolation for some individuals.  Wolf (1995)
followed the progress of 23 patients, the majority of whom experienced some type of
tonic-clonic seizure, and 14 of whom were treated with behavioral interventions only
following their first confirmed epileptic seizure.  Following one year, the relapse rate
was 30% (7 of 23 individuals), with 4 of 9 patients taking antiepileptic medications
experiencing further seizures.  Only 3 of 14 patients using behavioral management
techniques experienced further seizures following one year.  Given the absence of
sound methodology, thorough description of intervention, and statistical analysis,
these results can be interpreted only with extreme caution.  However, several other
researchers have suggested that antiepileptic medication may not always be the most
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efficacious treatment following a first seizure.  In a sample of 424 persons with
epilepsy, Annegers, Shirts, Hauser, and Kurland (1986) found an equal risk of seizure
recurrence for medicated and nonmedicated patients, but an increased risk after 5
years for individuals taking medication for idiopathic epilepsy.  Similarly, Hopkins,
Garman, & Clarke (1986) found no significant differences in rate of recurrence in 306
adults receiving either medication or no medication following their first seizure. 
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Rationale
Persons with mental retardation often have a multitude of impairing factors to
deal with in addition to deficits in intellectual ability and adaptive behavior. 
Comorbid psychological and physical problems occur at a higher rate in this
population than in persons of normal intelligence; epilepsy is one of the most
frequently occurring of these problems.  Occupational, social, and adaptive skill
acquisition opportunities can be hindered by epilepsy, and antiepileptic medications
often have potentially impairing and/or permanently damaging side effects.  As
demonstrated here, a large body of literature exists supporting an integrated, bio-
behavioral etiology of epilepsy.  Behaviorally-based interventions working from this
model have been implemented for treatment of this condition, and have been effective
in many cases.  Several efforts involving behavioral treatment of seizures in persons
with mental retardation have successfully reduced seizure frequency.  However,
proliferation of this approach into applied realms has not occurred.  Likely
contributing to this are the continued dominance of a medical approach to this
disorder, a lack of knowledge about the bio-behavioral model and successful
behavioral treatment efforts, and a dearth of systematic assessment methodology from
which such approaches can be accurately and efficiently generated.  A behavioral
approach to epilepsy in persons with mental retardation is especially attractive, as
treatment could become less dependent on medication which may further complicate
functioning.
40
Evidence of the viability of an integrated approach in treating epilepsy
continues to build.  The presence of identifiable physical and environmental
antecedents to a variety of seizure types has been demonstrated, and behavioral
interventions aimed at reducing seizure activity have been successfully conducted. 
However, no standardized assessment tools for such factors in persons with mental
retardation exist, and are needed to facilitate behavioral treatment efforts in this
population.  This project attempted to take the first steps in establishing such an
assessment measure by assessing the reliability and validity of a scale measuring
antecedents and consequences of seizures in persons with mental retardation. 
Relevant measures of reliability included test-retest, interrater, cross-rater, internal
consistency and construct validity of the questionnaire.  
Rating Scale Measurement in Persons with Mental Retardation
Rating scale measurement has recently become a primary method of assessing
a variety of psychological issues in persons with mental retardation.  This method
typically relies on information from someone familiar with the individual assessed,
such as a direct care staff or a family member.  This approach has proved especially
useful given the impracticality of methods like detailed behavioral observation and
experimental manipulation (e.g., functional analysis) and a reduced self-report
capacity often present in persons with mental retardation.  Rating scales have been
designed to measure a range of behavior specific to persons with mental retardation,
including psychopathology (Matson & Bamburg, 1998; Matson, Gardner, Coe, &
Sovner, 1991; Reiss, 1990), social skills (Matson, 1995; Matson, Helsel, Bellack, &
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Senatore, 1983), motivation for problem behavior (Durand & Crimmins, 1988;
Matson, Vollmer, Paclawskyj, Smirolodo, Applegate, & Stallings, 1996), and
medication side effects (Matson, Mayville, Bielecki, Barnes, Bamburg, & Baglio,
1998), among other areas.  Scales in all of these areas have proven reliable and valid
(e.g., Matson & Bamburg, 1995; Matson, LeBlanc, Weinheimer, & Cherry, 1999;
Matson et al., 1998).  Thus, measurement of behavior and environmental conditions
related to seizure behavior using a third-party report format would appear to be a
viable option.   
The M&M Scale
The Matson and Mayville (M&M) seizure scale is a tool designed to facilitate
behavioral assessment efforts specific to persons with mental retardation.  Items on
the M&M are representative of behavior thought to be related to seizure activity in
persons with mental retardation based on research in both mentally retarded and non-
mentally retarded populations (e.g., Antebi & Bird, 1993; Bruno-Golden & Holmes,
1993; Dahl, 1999; Fenwick, 1994, Zlutnick et al., 1975).  For example, items include
breathes rapidly, exhibits specific movements (e.g., raising hands), appears tired
or drowsy, appears scared or panicked, and appears sad or depressed, all of
which have been either hypothesized or confirmed to be related to behavioral factors
related to seizure occurrence.  Items are grouped into the following categories:
inducing, stress, anxiety, arousal, tension, depression, attention, escape, access, non-
social.  Categories have also been grouped into antecedent and consequence sections.  
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The M&M scale consists of the questionnaire itself as well as a score sheet. 
Contained in the questionnaire are spaces provided for the individuals demographic
information as well as information related to psychiatric diagnoses and antiepileptic
and psychotropic medication.  Additionally, there are spaces provided for the name of
the informant and the relationship of the informant to the client.  The informant
should have known the client for at least one year, have observed at least two
seizures, and should be in a position to observe pre, during, and post seizure behavior. 
The informant should also be told that how often the behavior occurs and how long it
has been occurring is of interest, not what he or she thinks a good answer should be.
Items have been designed using a Likert-type format, with three possible
responses for both frequency and duration of behavior: (0) never occurs, (1)
sometimes occurs, and (2) always occurs for frequency ratings; and (0) less than one
month, (1) 1 to 12 months, and (2) longer than 12 months for duration ratings.  This
format provides staff with simple yet descriptive options, and has been successful in
the identification of medication side effects (see Advokat, Mayville, & Matson, 2000
and Matson et al., 1998).  
The score sheet contains spaces for relevant demographic information,
including name, gender, date of birth, date of interview, informants name, and
relationship of the informant to the client.  The frequency score for each item as
indicated on the questionnaire is also provided on the score sheet, scored 0 through 2
for each item.  The total frequency score within a question category should be
indicated by drawing a circle around the total frequency score for each category.  For
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example, the anxiety subscale contains items 1, 7, 19, and 26.  If item 1 is scored 2-
always occurs and item 7 is scored 1-sometimes occurs, the number 3 would be
circled.  Total duration scores are not calculated, but can be useful in determining the




All participants reside at either Pinecrest Developmental Center in Pineville,
Louisiana (PDC), or at Hammond Developmental Center in Hammond, Louisiana
(HDC).  Both PDC and HDC are residential developmental centers; PDC houses
approximately 650 persons with mental retardation, while HDC houses approximately
340.  Residents live in individual homes at the centers and receive constant
supervision from at least one staff member at all times.  Institutional Review Board
approval for this project was obtained through a previously approved research
proposal entitled: Norming Psychological Assessment Battery for Treatment Plans.
A total of 115 participants diagnosed with a seizure disorder and mental
retardation were included in the reliability portion of the study.  An additional 50
individuals with mental retardation and no seizure disorder served as controls in the
validity portion of the study.  Participants in all phases of the study were
predominantly caucasian, profoundly mentally retarded, and between the ages of 22
and 45.  The total sample was approximately 65% male, but the subsamples of
participants in the reliability and validity studies were more evenly split on this
variable.  With the exception of individuals in the control group of the validity study,
all participants were taking at least one antiepileptic medication, with 44% of the total
sample taking two medications.  Participants displayed a wide range of seizure
frequency during the previous year that data was collected; frequencies in the total
sample ranged from two to 111, with a mean frequency of approximately 15.  Because
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different subgroups of the 115 participants were included in the examinations of
reliability and validity, specific demographics for each study are discussed and
presented separately below.   
All 115 participants were used in the assessment of internal consistency, the
demographics for whom were described in the previous section.  Participants were
taking a  wide range of antiepileptic medications, the most frequent of which were
divalproex, phenytoin, and carbamazepine.  The majority of participants were taking
either one or two medications.  Demographic information for the internal consistency
group is contained in Table 1.
Table 1: Demographic Characteristics for Participants in the Internal Consistency
Sample (N=115).
               Demographic        Percent of sample
Age
0-21                              2.61   
22-45                            67.82
46-65                            26.09     
66+                              3.48   
Gender
male                            65.20      
female                            34.80     
Race
Caucasian                            74.80       
African American                            24.30       
Hispanic American                              0.90     
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Level of Mental Retardation
Mild                              1.70
Moderate                              4.30       
Severe                              4.30  
Profound                            87.80      
Unspecified                              1.70       
Seizure Frequency (past year)               Number of Seizures
Mean                             15.53
SD                             15.71
Minimum                               2.00
Maximum                           111.00
Antiepileptic Medications             Percent of Sample
1 med                              37.4
2 meds                              44.3
3 meds                              12.2
4 meds                                6.1
divalproex                              25.2
phenytoin                              21.7
carbamazepine                              16.5
phenobarbital                              14.8
gabapentin                                2.6
Valproic Acid                                6.1
Klonopin                                1.7
primidone                                1.7
oxcarbazepine                                1.7
diazepam                                1.7
felbamate                                0.9
lamotrigine                                0.9
toprimate                                0.9
47
Participants in all of the reliability samples reflected similar demographic
characteristics as the total sample.  Individuals in the inter-rater sample were slightly
more evenly matched for the variable of gender, but were a bit more young (82% in
22-45 age group, vs 67% in total sample), evinced seizures more frequently (mean =
23 in past year, vs 15 in total sample), and reflected less monotherapy for antiepileptic
medication (29% vs. 37%) than the total sample.  Individuals having relatively
frequent seizures (15 to 20 in past year) were given priority for assessment in all of
the reliability groups to facilitate adequate recall of events related to the seizures. 
With the exception of the test-retest sample, seizure frequencies for all groups were
within one standard deviation of the mean of the total sample.  Demographic
information for this sample is contained in Table 2.
Table 2: Demographic Characteristics for Participants in the Inter-Rater Sample
(N=17).
             Demographic        Percent of sample
Age                           
0-21                            0.00    
22-45                           82.40 
46-65                           17.60
66+                             0.00    
Gender
male                            41.20    
female                            58.80  
Race
Caucasian                            76.50     
African American                            23.50
                                                                             (table continued)
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Level of Mental Retardation
Mild                              0.00
Moderate                              5.90                   
Severe                              0.00               
Profound                            88.20                 
Unspecified                              5.90                
Seizure Frequency (past year)               Number of Seizures
Mean                            23.47
SD                            12.66  
Minimum                              2.00    
Maximum                            57.00
Antiepileptic Medications               Percent of Sample
1 med                              29.4 
2 meds                              41.2
3 meds                              17.6
4 meds                              11.8
Participants in the cross-rater sample were one fewer than the other reliability
samples.  Individuals in this sample deviated from the total sample most noticeably on
the variables of gender (50% male and female in cross-rater, 65-35% male and
female, respectively, in total sample), level of mental retardation (100% profound in
cross-rater group), and seizure frequency for the past year (32 in cross-rater, 15 in
total sample).  Demographic characteristics for participants in the cross-rater sample
are presented in Table 3.
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Table 3: Demographic Characteristics for Participants in the Cross-Rater Sample
(N=16).
               Demographic        Percent of sample
Age                           
0-21                          0.00      
22-45                         68.80   
46-65                         31.20  
66+                           0.00      
Gender
male                           50.0     
female                           50.0   
Race
Caucasian                           68.8
African American                           31.2
Level of Mental Retardation
Mild                            0.00
Moderate                            0.00
Severe                            0.00
Profound                        100.00 
Unspecified                            0.00
Seizure Frequency (past year)               Number of Seizures
Mean                          32.75
SD                          25.47  
Minimum                            3.00
Maximum                     111.00
Antiepileptic Medications             Percent of Sample
1 med                            31.2
2 meds                            37.5
3 meds                            12.5
4 meds                            18.8                                
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Participants in the test-retest group closely reflected the demographic
characteristics of the total sample for most variables, with the exception of gender
(fewer males (48% vs 65%) and seizure frequency in the previous year (32 in cross-
rater, 15 in total sample).  Demographic information for this sample is contained in
Table 4.
Table 4: Demographic Characteristics for Participants in the Test-Retest Sample
(N=17).
Demographic        Percent of sample
Age                           
0-21                             0.0        
22-45                           69.6
46-65                           26.1
66+                             4.3  
Gender
male                            47.8    
female                            52.2
Race
Caucasian                            82.6
African American                            17.4
Level of Mental Retardation
Mild                             1.7
Moderate                             1.7
Severe                             4.3
Profound                           88.0 
Unspecified                             4.3
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Seizure Frequency (past year)               Number of Seizures
Mean                          32.75
SD                          25.47  
Minimum                            3.00
Maximum                        111.00
Antiepileptic Medications             Percent of Sample
1 med                            30.4
2 meds                            43.5
3 meds                            17.4
4 meds                              8.7
Individuals in the validity groups consisted of two groups of 50, one
consisting of individuals with a seizure disorder, the other of individuals without a
seizure disorder who were individually matched on the variables of age, gender, and
level of mental retardation to the seizure group.  Selection of participants in the
seizure group involved the following process: individuals in the total sample were
listed randomly according to a random numbers table, and 25 males and 25 females
were then selected from this list in top to bottom of the list, alternating fashion.
Demographic characteristics for both groups resembled those found for the total
seizure disorder sample.  Demographics for the validity sample are presented in Table
5.
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Table 5.  Demographic Information for Seizure Disorder and No Seizure Disorder
Groups.
       Seizure Disorder         No Seizure Disorder         
(N = 50)                  (N = 50)              
Percent of Sample
__________________________________________________________________________
Mean  Age (years)      
    0-21   4.0   6.0
  22-45 62.0 60.0
  46-65 28.0 30.0
  66+   6.0   4.0
Gender
   Male               50.0 50.0
   Female 50.0 50.0
Race
   Caucasian 66.0 72.0
   African American 32.0 28.0
   Hispanic   2.0
Level of MR
   Mild   4.0    2.0
   Moderate   4.0   6.0
   Severe   4.0 16.0
   Profound               88.0 72.0
   Unspecified   0.0   4.0 
Procedure
Data for all participants was collected through interviews with developmental
center care staff who work directly with the participant and had witnessed at least two
seizures during the past year.  Graduate student raters interviewed direct care staff
who met the requirement of having observed at least two seizures in the individual
during the past year (see Appendix A).  Because of possible difficulty in staff
identifying more subtle seizure subtypes (e.g., absence, complex partial), all
participants had received a diagnosis of tonic-clonic epilepsy from a staff neurologist. 
All participant demographic data was collected from the participants medical chart at
the developmental center.  Specific procedures for each section of the study are
presented in the following subsections.    
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Internal Consistency
The internal consistency of the M&M subscale and total antecedent and
consequence scales was assessed through calculation of coefficient alpha, a measure
of item homogeneity and how well item content has been sampled (Anastasi &
Urbina, 1997; Cronbach, 1951).  Data from a total of 115 residents was collected. 
Interviewers were one of four LSU graduate students in clinical psychology trained to
administer the M&M by the second author of the scale.  
Inter-Rater Reliability
To examine error variance due to interscorer differences (Anastasi & Urbina,
1997), the degree of correspondence of responses between independent raters (LSU
graduate students) was assessed for 17 participants.  All participants in all of the
reliability experiments were selected from the internal consistency reliability pool of
115.  Two interviewers simultaneously scored responses from one informant, and the
correlation between these tests was calculated.  
For this sample and the cross-rater and test-retest samples, Pearson product-
moment correlation coefficients were conducted to determine correspondence for total
and subscale scores (Anastasi & Urbina, 1997).  Given the ordinal nature of the Likert
ratings for items, Spearman rank-order correlations were conducted for individual
items (Siegel & Castellan, 1988). 
Cross-Rater Reliability
Because the M&M is a measure of behavior observed by a third party and not
directly by the trained raters, it was necessary to assess variance due to both direct
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observer and trained rater error.  Calculation of correspondence between care staff
members directly observing behavior was conducted for 16 participants to address the
former of these issues.  A graduate student interviewer completed two separate M&M
scales with two different direct care staff working with the same participant.  Length
of time between the two administrations was kept under 24 hours.  The same
interviewer conducted both assessments; that is, the interviewer completed one
assessment with one staff person, and then assessed another staff member working
with the same client.   
Test-Retest Reliability  
To assess error variance due to time sampling, 16 M&Ms were re-
administered by the same interviewer to the same informant approximately two weeks
following the first administration.  The correlation between these two administrations
was then assessed.   
Validity
Analyses of validity often include assessment of correspondence between the
measure of interest and measures of similar constructs (concurrent and convergent
validity) as well as, divergence from constructs the test should not correlate with
(Anastasi & Urbina, 1997; Cohen, Swerdlik, & Phillips, 1996).  Such analyses are
difficult to conduct with a scale such as the M&M, as currently no appropriate
comparison measures exist.  However, construct validity was investigated through
several analyses.  First, internal consistency provides a measure of construct
homogeneity for both subscales and total test score, as well as providing the
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aforementioned reliability information.  Second, comparison of test scores from
individuals in distinct groups (e.g., persons with mental retardation and a seizure
disorder and persons with mental retardation and no seizure disorder) should reveal a
differential pattern of responding related to the construct of interest (Cohen et al.,
1996).  Thus, the M&M was administered to a group of 50 individuals without a
seizure disorder who were matched on relevant variables to a randomly selected group
of 50 from the internal consistency sample (see Appendix B).  One-way analyses of
variance (ANOVA) were conducted to detect group differences for M&M subscales
and total antecedent and consequence scales.  
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Results           
Internal Consistency
Internal consistency was assessed for the antecedent subscales through
calculation of coefficient alpha, an estimate of reliability based on the average
correlation between items and the total number of items.  This statistic was completed
for each individual antecedent subscale as well as for the total antecedent and
consequence scales.  Alphas were not calculated for individual consequence
subscales, as each subscale contains only two items.  Results are displayed in Tables 6
and 7.
Table 6: Coefficient Alphas for M&M Antecedent Subscales.
Subscale                                                 Alpha
Inducing       .125
Stress       .011
Anxiety       .338
Arousal       .127
Tension       .334
Depression       .474
TOTAL ANTECEDENT       .398
TOTAL CONSEQUENCE       .463
Table 7.  Coefficient Alphas with Each Individual Item Deleted.
Item                                                                                                         Antecedent alpha if item deleted
     1. Trembles or shakes. .3806
     2. Appears angry or agitated.         .3583
     3. Hits self. .3798
     4. Loud/noisy environment.    .3886
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     5. Engages in purposeful seizure-like behavior. .3936
    6. Is physically active (e.g., running, walking). .4193
     7. Appears scared or panicked. .3973
     8. Muscles appear tense. .3539
     9. Is verbally aggressive toward others. .3957
    10. Is resting or relaxing. .4287
    11. Appears excited or aroused. .3937
    12. Appears tired or drowsy. .3877
    13. Appears sad or depressed. .3783
    14. Sudden change in activities. .4033
    15. Cries for no apparent reason. .3922
    16. Hits or kicks other people. .3800
    17. Seems to be saying "leave me alone" or "stop asking me to do   
            this".
.4024
    18. Is yelled at or spoken to harshly by others. .3982
    19. Breathes rapidly (hyperventilation) .3813
    20. Is asked to complete a task or engage in an activity. .4014
    21. Appears to be saying "look at me".   .3915
    22. Has not been sleeping well; is sleep deprived. .3935
    23. Exhibits specific movements (e.g., raising hands). .3935
    24. Responds slowly (response latency after prompt). .3560
    25. Is not engaged in any activities. .4151
    26. Cannot relax. .3826
    27. Lacks interest in preferred activities. .3326
Consequence alpha if item
deleted
   28. Appears happy or content (e.g., smiles). .5055
   29. Is allowed to escape work or learning situation. .3293
   30. Individual appears more relaxed after seizure.  .4462
                 (table continued)
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   31. Is attended to by staff and/or peers. .4065
   32. Is left alone by staff and/or peers following seizure. .4405
   33. Is given special privileges (e.g., allowed to go to special room    
          or area).
.4091
   34. Receives special medical attention (e.g., is  immediately             
          attended to by nurse or doctor, is given medication, etc.). 
.4353
   35. Is given access to special items (e.g., preferred food  or drink).   .4320
Inter-Rater Reliability
To assess correspondence of scores between graduate student raters, Spearman
rank-order correlation coefficients were computed for individual items, and Pearson
product-moment correlations were conducted for subscales and for total antecedent
and consequence scores.  Overall, correlations were high, with 59% of item
correlations and 75% of subscale and total scale correlations exceeding the minimally
acceptable value of .80 (Nunnally, 1994).  Results of subscale and total scale inter-
rater correlations are presented in Table 8, and inter-rater statistics and mean scores
for individual items are presented in Table 9.
Table 8.  M&M Subscale and Total Scale Inter-Rater Reliability Correlation
Coefficients.
Subscale Correlation
Inducing       1.00**
Stress       .339
Anxiety       .966**
Arousal       .912**
Tension       .893**
Depression       .933**
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Attention       .839**
Escape       .696**
Access       .877**
Nonsocial       .865**
TOTAL ANTECEDENT       .791**
TOTAL CONSEQUENCE       .809**
**Denotes significance at the .01 level.
Table 9.  M&M Item Inter-Rater Reliability Correlation Coefficients and Mean
Scores for Raters.
 Mean          Mean
Item                                                                                                    Spearman       rater 1         rater 2
     1. Trembles or shakes. .729** .176 .117
     2. Appears angry or agitated.         .647** .529 .294
     3. Hits self. 1.00** .352 .352
     4. Loud/noisy environment.    .764** .529 .529
     5. Engages in purposeful seizure-like behavior.   ----- .000 .000
     6. Is physically active (e.g., running, walking). .729** .117 .176
     7. Appears scared or panicked. 1.00** .117 .117
     8. Muscles appear tense. .825** .470 .352
     9. Is verbally aggressive toward others. .638** .176 .058
    10. Is resting or relaxing. .497* 1.176 1.117
    11. Appears excited or aroused. .475 .529 .470
    12. Appears tired or drowsy. .652** .470 .529
    13. Appears sad or depressed. 1.00** .176 .176
    14. Sudden change in activities. 1.00** .352 .352
    15. Cries for no apparent reason. 1.00** .117 .117
    16. Hits or kicks other people.   ---- .000 .000
    17. Seems to be saying "leave me alone" or "stop asking me to  
          do this".
  ---- .000 .000
    18. Is yelled at or spoken to harshly by others.   ---- .000 .000
    19. Breathes rapidly (hyperventilation)   ---- .000 .000
         (table continued)
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    20. Is asked to complete a task or engage in an activity.   ---- .000 .000
    21. Appears to be saying "look at me".   1.00** .058 .058
    22. Has not been sleeping well; is sleep deprived. 1.00** .058 .058
    23. Exhibits specific movements (e.g., raising hands). 1.00** .647 .647
    24. Responds slowly (response latency after prompt). .878** .294 .411
    25. Is not engaged in any activities. .359 1.00 1.05
    26. Cannot relax. 1.00** .352 .352
    27. Lacks interest in preferred activities.   ---- .000 .000
   28. Appears happy or content (e.g., smiles). .843** .529 .647
   29. Is allowed to escape work or learning situation. .911** 1.47 1.35
   30. Individual appears more relaxed after seizure.  .850** .941 1.05
   31. Is attended to by staff and/or peers. 1.00** 1.82 1.82
   32. Is left alone by staff and/or peers following seizure. .576* .294 .117
   33. Is given special privileges (e.g., allowed to go to special       
          room or area).
.880** .823 .882
   34. Receives special medical attention (e.g., is immediately        
          attended to by nurse or doctor, is given medication, etc.). 
.540* 1.88 1.64
   35. Is given access to special items (e.g., preferred food or         
          drink).   
.729** .117 .235
**Denotes significance at the .01 level.
 Denotes correlation was not completed because at least one of the values was constant.
Cross-Rater Reliability
To assess correspondence of scores between direct-care staff informants,
Spearman rank-order correlation coefficients were computed for individual items, and
Pearson product-moment correlations were conducted for subscales and for total
antecedent and consequence scores.  Overall, correlations were low, ranging from-
.067 to .617 for subscales and -.067 to .692 for individual items.  Results of subscale
and total scale cross-rater correlations are presented in Table 10, and cross-rater
statistics and mean scores for individual items are presented in Table 11.
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*Denotes significance at the .05 level.
Table 11.  M&M Item Cross-Rater Reliability Correlation Coefficients and Mean
Scores for Raters.
 Mean            Mean
Item                                                                                               Spearman     Informant 1   Informant 2
     1. Trembles or shakes. .297 .250 .500
     2. Appears angry or agitated.         .692* .250 .187
     3. Hits self.   ---- .125 .000
     4. Loud/noisy environment.    .516* .625 .500
     5. Engages in purposeful seizure-like behavior.   ---- .000 .000
     6. Is physically active (e.g., running, walking). -.142 .187 .187
     7. Appears scared or panicked. -.123 .250 .062
     8. Muscles appear tense. -.017 .437 .500
     9. Is verbally aggressive toward others. -.067 .062 .062
                                                  (table continued)
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    10. Is resting or relaxing. .611* 1.12 1.12
    11. Appears excited or aroused. .602* .562 .375
    12. Appears tired or drowsy. -.072 .625 .312
    13. Appears sad or depressed. -.098 .125 .062
    14. Sudden change in activities. .383 .312 .062
    15. Cries for no apparent reason.   ---- .062 .000
    16. Hits or kicks other people.   ---- .000 .125
    17. Seems to be saying "leave me alone" or "stop asking me to  
          do this".
  ---- .000 .000
    18. Is yelled at or spoken to harshly by others.   ---- .000 .000
    19. Breathes rapidly (hyperventilation) .683* .062 .125
    20. Is asked to complete a task or engage in an activity.   ---- .000 .125
    21. Appears to be saying "look at me".   -.067 .062 .125
    22. Has not been sleeping well; is sleep deprived.   ---- .062 .000
    23. Exhibits specific movements (e.g., raising hands). .175 .687 .250
    24. Responds slowly (response latency after prompt). .389 .250 .312
    25. Is not engaged in any activities. .493 1.12 1.37
    26. Cannot relax. .164 .312 .187
    27. Lacks interest in preferred activities.   ---- .000 .125
    28. Appears happy or content (e.g., smiles). .308 .562 .312
    29. Is allowed to escape work or learning situation. .537* 1.18 1.25
    30. Individual appears more relaxed after seizure.  .020 .562 .187
    31. Is attended to by staff and/or peers. -.067 1.93 1.87
    32. Is left alone by staff and/or peers following seizure. .617* .250 .125
    33. Is given special privileges (e.g., allowed to go to special      
           room or area).
.346 .937 .812
    34. Receives special medical attention (e.g., is immediately       
           attended to by nurse or doctor, is given medication, etc.). 
  ---- 2.00 2.00
    35. Is given access to special items (e.g., preferred food or        
           drink).   
.303 .125 .187
 Denotes correlation was not completed because at least one of the values was constant.
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Test-Retest Reliability
To assess the consistency of scores over time,  Spearman rank-order
correlation coefficients were again computed for individual items, as were Pearson
product-moment correlations for subscales and for total antecedent and consequence
scores.  Again, correlations were mostly low, but did range from -.032 to .735 for
subscales and -.097 to 1.00 for individual items.   Results of subscale and total scale
test-retest correlations are presented in Table 12, and inter-rater statistics and mean
scores for individual items are presented in Table 13.
Table 12.  M&M Subscale and Total Scale Test-Retest Reliability Correlation
Coefficients.













**Denotes significance at the .01 level.
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Table 13.  M&M Item Test-Retest Reliability Correlation Coefficients and Mean
Scores for Raters.
Mean            Mean
Item                                                                                                 Spearman       Time 1          Time 2
     1. Trembles or shakes. -.180 .187 .250
     2. Appears angry or agitated.         .826** .500 .625
     3. Hits self. .730** .187 .125
     4. Loud/noisy environment.    -.169 .437 .562
     5. Engages in purposeful seizure-like behavior. 1.00** .062 .062
     6. Is physically active (e.g., running, walking). .730** .125 .187
     7. Appears scared or panicked.   ---- .250 .000
     8. Muscles appear tense. .137 .375 .375
     9. Is verbally aggressive toward others. .633** .187 .062
    10. Is resting or relaxing. .374 1.06 1.18
    11. Appears excited or aroused. -.123 .312 .062
    12. Appears tired or drowsy. .350 .500 .250
    13. Appears sad or depressed. .303 .187 .125
    14. Sudden change in activities. .289 .375 .187
    15. Cries for no apparent reason. .463 .125 .187
    16. Hits or kicks other people. .683** .062 .125
    17. Seems to be saying "leave me alone" or "stop asking me to  
           do this".
  ---- .000 .125
    18. Is yelled at or spoken to harshly by others.   ---- .000 .000
    19. Breathes rapidly (hyperventilation) .392 .125 .187
    20. Is asked to complete a task or engage in an activity.   ---- .000 .125
    21. Appears to be saying "look at me".     ---- .062 .000
    22. Has not been sleeping well; is sleep deprived. -.097 .062 .187
    23. Exhibits specific movements (e.g., raising hands). .579* .687 .562
    24. Responds slowly (response latency after prompt). .577* .375 .500
    25. Is not engaged in any activities. .303 1.25 1.25
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    26. Cannot relax. -.181 .312 .250
    27. Lacks interest in preferred activities. .481 .125 .437
    28. Appears happy or content (e.g., smiles). .500* .187 .187
    29. Is allowed to escape work or learning situation. .220 1.18 1.25
    30. Individual appears more relaxed after seizure.  .596* 1.00 .750
    31. Is attended to by staff and/or peers. .683** 1.87 1.75
    32. Is left alone by staff and/or peers following seizure.   ---- .000 .125
    33. Is given special privileges (e.g., allowed to go to special      
            room or area).
.366 .875 .750
    34. Receives special medical attention (e.g., is immediately       
            attended to by nurse or doctor, is given medication, etc.). 
.214 1.68 1.81
    35. Is given access to special items (e.g., preferred food or        
           drink).   
.481 .062 .437
 Denotes correlation was not completed because at least one of the values was constant.
Validity
To assess differences between the seizure and no-seizure group for M&M
subscale and total scores, separate one-way analyses of variance (ANOVA) were
conducted using seizure status as the independent variable and subscale and total
score as the dependent variable.  Results of these analyses and means and standard
deviations are presented in Table 14.  
Table 14.  Mean (M) and Standard Deviation (SD) of the Subscale and Total Scale
Frequency Ratings, F Values, and Significance Values on the M&M for Each Group.
Subscale           Seizure Group No Seizure Group         F                 p value
Inducing
   Mean
    SD
   .540
   .813     
   1.10
   .886
   
   10.83    .001
Stress
   Mean
    SD
   .480
   .706   
   2.74
   1.83
   65.82
    
   .000
      (table continued)
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Anxiety
   Mean
    SD
   
  .440
  .812
   .440
   .836
     .000     1.00
Arousal
   Mean
    SD
  2.44
  1.43
   4.40
   1.60
   41.58
     
   .000
Tension
   Mean
    SD
  1.18
  1.25
   1.86
   1.62
     5.46    .021
Depression
   Mean
    SD
  .900
  1.44
   1.00
   1.12
     .149    .700
Attention
   Mean
    SD
   3.50
   .931
   2.30
  .909
   42.50    .000
Escape
   Mean
    SD
  1.36
  1.00
   .960
   .781
     4.93    .029
Access
   Mean
    SD
  .740
  .876
   1.72
   1.19
   
   21.84    .000
Nonsocial
   Mean
    SD
  1.26
  1.00
   2.16
   1.31
   14.77    .000
TOTAL ANTECEDENT
   Mean





   42.51    .000
TOTAL CONSEQUENCE
   Mean






     .414    .521
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Discussion
The present study evaluated the internal consistency, inter-rater, cross-rater,
test-retest, and construct validity of the Matson and Mayville seizure scale.  Based on
the results of analyses investigating these psychometric properties, the following
conclusions are made. 
Internal Consistency and Reliability
Results of coefficient alphas for the M&M  total antecedent and consequence
scales suggests low internal consistency of each of these scales.  Because these scales
contain a number of heterogenous constructs, this result was not surprising. 
However, low internal consistencies for each of the subscales were not expected
given reports in the literature of pre-seizure phenomenon and post-seizure
consequences occurring in what appear to be distinct groups, all of which are
represented in the M&M scale (Antebi & Bird, 1993; Bruno-Golden & Holmes,
1993; Dahl, 1992, 1999; Fenwick, 1994).  Several possible explanations exist for this
outcome.  First, it is possible that experience, expression, and occurrence of seizure-
related environmental and behavioral variables are represented differently in
individuals with severe and profound mental retardation.  This, in turn, might affect
responding to items largely extrapolated from the literature concerning individuals of
normal intelligence.  Second, it is possible that direct care staff are capable of
recognizing a limited number of pre and post seizure occurrences; many of the
previous studies in this area have been based primarily on self-report (e.g., Antebi &
Bird; Dahl, 1992).  Moreover, the statistical coherence of item groupings for any
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population is currently unknown, as researchers have yet to attempt this task even for
persons within the normal range of intelligence.  Thus, further research is needed in
all populations to establish the feasibility of factor groupings of factors influencing
seizure initiation and maintenance.  However, while the notion of item homogeneity
is a potentially important component of both reliability and construct validity, it may
not be essential to clinical utility.  Subsequent studies may reveal that a small number
of isolated items accurately describe these phenomenon and are associated with a
beneficial treatment outcome (e.g., Daniels, 1975; Iwata & Lorentzson, 1976;
Zlutnick et al., 1975).              
Inter-rater reliability coefficients for the total scales and subscales suggest that
graduate student raters can reliably rate M&M items based on responses from direct
care staff.  Overall, subscale and individual item correlations were high, with the
exception of the Stress subscale.  However, as illustrated in Table 9, item correlations
for the two of the five items for which correlations could be completed (Loud/noisy
environment; Is verbally aggressive toward others), each had good correlations. 
This suggests that when considered individually, items in the stress subscale can be
rated by interviewers reliably.  Lower correlations were found for five items in the
M&M scale, items 10, 11, 25, 32, and 34, suggesting that raters experienced some
degree of difficulty interpreting informants responses.  Informants communicated
their answers by stating the frequency description rather than the number representing
that frequency.  It is likely that stating the number of the ranking only would increase
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inter-rater reliability, and this format will be included in the protocol for
administration of the instrument.
In contrast to high inter-rater reliability coefficients, cross-rater reliability
coefficients were considerably lower, suggesting that direct care staff disagree on
occurrence of a number antecedent and consequence events as measured by the
M&M.  Subscale correlations were highest for the Arousal, Tension, and Escape
subscales, and all were statistically significant.  Items contained in these subscales
represent behaviors which can be easily confirmed or disconfirmed, such as is
physically active, appears angry or agitated, is allowed to escape work or
learning situation, and is left alone by staff and/or peers following seizure.  The
latter two items are related to procedure for managing seizures followed by all staff at
the developmental centers, so higher reliability for these items would be expected. 
That is, staff are instructed never to leave the individual alone directly following a
seizure, and are to help them to bed if they are tired following the incident.  A weak
negative correlation was found for the item Is attended to by staff or peers, also an
item related to developmental center procedure.  An inspection of mean and
individual scores for this item reveals very high item endorsement, almost constant in
the case of Informant 1.  Slightly lower scores for Informant 2 on this item account
for the negative direction and lower magnitude of the correlation.  Similarly, a
correlation could not be computed for the item Receives special medical attention
because this occurs following every seizure in accordance with developmental center
policy.  However, with the exception of only a few items, most items in these
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subscales had low endorsement rates (means under 1.0), suggesting that staff are
more sure about non-occurrence than occurrence of these behaviors or events.
Overall low item and subscale correlations between informants were not
expected and were somewhat disappointing, especially given the relatively high
frequency of seizure in this group during the past year.  However, several positive
points are apparent for future study.  First, somewhat acceptable correlations were
found for several items on both the antecedent and consequence scales, some of
which reflected moderate endorsement rates.  As such, select items may prove to be
more useful than others in facilitating behavioral interventions for seizures.  Items for
which significant correlations were recorded and for which item endorsement was
closer to one than to zero were those which represented a broad situational context, or
setting event (Bijou & Baer, 1961).  Thus, direct care staff appear to be able to agree
on events preceding seizures which involve non-discrete, situational variables as
opposed to specific, distinct antecedents.  However, an alternative explanation is that
more specific antecedent events were not common in this sample, and that
presentation was subtle when they did occur.  The prevalence of behavioral and
environmental contributors in persons with mental retardation is currently unknown;
a low base-rate of such phenomenon is possible.  Future research regarding
prevalence of such events will help facilitate meaningful interpretation of
endorsement rates of M&M items, as well as consistency in ratings between direct
care staff.
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Results of test-retest analyses also revealed overall low correlation
coefficients for M&M subscales.  A significant correlation was found for the
Nonsocial subscale only.  Items contained in this subscale include appears to be
happy or content and individual appears more relaxed after a seizure, the former
of which was endorsed infrequently (mean = .187) and the latter of which was
endorsed relatively more frequently (mean = approx. 1.00).  Interviewers explained to
informants that relaxed did not mean sleeping, but rather a conscious state that
involved obvious muscle relaxation.  However, given the relatively high frequency of
the endorsement of this item, and the high rate of sleeping following tonic-clonic
seizures (Dreyfuss, 1981) it is possible that informants still included sleeping in
answering this item.  As such, it will be important for interviewers to carefully
explain the meaning of this item to informants providing ratings for individuals who
have tonic-clonic seizures.  This item may prove to be more useful in assessing
persons experiencing types of seizures other than tonic-clonic (e.g., simple or
complex partial).   
An inspection of individual item correlations revealed more positive findings
regarding test-retest reliability of the M&M.  Good correlations were found for
approximately ten individual items, the majority of which were endorsed
infrequently.  Again, explanations for low endorsement could be either that direct
care staff miss these events when they occur, or that they can consistently identify
phenomenon that occur infrequently.  Several items reflected good correlations with
relatively high item endorsement.  Among these items were Exhibits specific
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movements, e.g., raising hands, and Appears angry or agitated, both of which
appear to be distinctive enough for staff to be able to report them consistently across
time.  In contrast to those items found to have good reliability in the cross-rater
sample, items rated reliable across time tended to be more specific events, not setting
events.  Overall, evidence of good test-retest reliability was apparent in individual
items more so than subscales, suggesting that for individuals with severe and
profound mental retardation who experience tonic-clonic seizures, consistent results
can be obtained across time for a sub-sample of items interpreted independent of
subscale membership.
Validity
The assessment of construct validity compared scores on the M&M total
scales and subscales between two groups of individuals with severe and profound
mental retardation: one diagnosed with a seizure disorder and one group without this
diagnosis.  Individuals were matched where possible on the demographic variables of
age, gender, and level of mental retardation.  Results revealed significant differences
for all but three dependent variables, Anxiety, Depression, and Total Consequence. 
However, differences were in the opposite direction than expected, as the no seizure
group recorded higher scores than the seizure group for seven of the nine scales on
which significant differences were found.  The reason for this became apparent early
in the data collection phase, as questions lost context when asked without regard to a
specific event.  For example, the question, Is asked to complete a task or engage in
an activity would be answered 1, sometimes occurs for persons without a seizure
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disorder, as they sometimes are asked to engage in certain activities.  When not tied
to a specific event, questions become surveys of general behavior, not inquiries about
antecedent and consequences of a particular event.  Interestingly, scores were higher
in the control group for the Inducing subscale, an area in which the seizure disorder
group was expected to reflect higher scores, even in light of this problem (Fenwick,
1981; Finkler, Lozar, & Fenwick, 1990).  This suggests that behaviors such as
engaging in purposeful, seizure-like behavior, and rapid breathing occur to some
degree in individuals without seizure disorders.  As such, these behaviors may need
more thorough investigation before labeled as factors contributing to seizure
frequency in persons with mental retardation.                   
Significant differences in the expected direction were found for the Attention
and Escape subscale, an effect attributable to the relationship between items on this
scale and procedures followed by staff following a seizure.  Thus, in interpreting the
contribution of these factors to maintenance of seizure activity, it is necessary to
thoroughly investigate attention and escape variables, as opposed to inferring a
function underlying seizure activity based on responses to these items.  If attention or
escape were maintaining seizures to some degree, one might also expect the
individual to be engaging in some type of inducing behavior to elicit the desired
response from others (Bruno-Golden & Holmes, 1993; Iwata & Lorentzson, 1976). 
At this point, it is unclear if this occurred, and if so, how often and in what form.  
Several steps need to be taken before the validity of the M&M can be
established. Because good reliability of measures is a prerequisite for validity, steps
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must be taken to first improve the reliability of this instrument (Cook & Campbell,
1979).  This can be accomplished through several means, starting with teaching staff
to record antecedent, behavior, and consequence information as seizures occur.  The
present format of the M&M requires staff to call upon their memory of factors
surrounding a potentially dramatic event with a sudden onset.  In some cases, staff
were drawing upon their memory for only two seizures during the past year. 
Therefore, recording events preceding and following seizures as they occur would
likely increase thorough and accurate responding to items designed to measure
specific pre and post seizure behavior (Dahl, 1992; Fenwick, 1994).  Second,
educating direct care staff about the interaction of environmental and biological
factors in seizure initiation and maintenance may help alert them to the presence of
factors they may have previously gone undetected (Dahl, 1992).  During the M&M
interviews, staff would often remark something like, It doesnt matter where he is or
what he is doing, he just has them.  While this may be true in many cases, staff may
not be prepared to observe more subtle environmental contributors in those instances
where such factors may largely influence seizures.  Third, data is needed for persons
with mild and moderate mental retardation, as it is quite possible that symptom
presentation varies with severity of impairment.  This is true with symptoms of
psychopathology, with detection of symptoms often becoming more difficult as
intellectual and adaptive functioning decreases (Singh, Sood, Sonenklar, & Ellis,
1991).  If contributing variables to seizures are more easily identified as functioning
increases, it is likely that the reliability of ratings would be better for persons who
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have mild and moderate impairment.  Subsequent research may reveal that this line of
assessment may be more productive when severity of mental retardation is accounted
for in item content, such as in different assessments for persons with mild and
moderate vs. severe and profound retardation.
            Additionally, further investigation of the psychometric properties of the
M&M scale is needed including individuals who experience a variety of seizure
types.  Simple and complex partial seizures are often preceded by particular motor,
emotional, and/or sensory signs (Antebi & Bird, 1993; Dahl, 1999; Wolf, 1995). 
However, these types of seizures can be very difficult to identify, particularly in
persons with severe and profound impairment (Iivanainen, 1999).  A psychometric
evaluation of the M&M involving persons with mild and moderate mental retardation
who experience simple and partial complex seizures would help elucidate the
conditions under which this instrument can yield reliable information.  Given that
persons with less impairment tend to be more verbal, the component of self-report of
seizure experience may significantly boost the reliability and validity of the M&M.     
    Once reliability is established, more appropriate tests of validity can be
conducted.  Because specific behaviors may serve a variety of functions in the same
or different contexts, a treatment group vs. control group comparison such as the one
employed here is insufficient to demonstrate the validity of the M&M as a functional
assessment instrument.  For example, a variety of events used as a control (e.g.,
physical aggression, self-injury) could be maintained by the same function as
seizures, depending on the extant contingencies for each event.  This concept would
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apply to any type of control behavior.  Such a comparison, however, is appropriate
for assessing base rates of particular behaviors without regard to function; results of
this assessment are reported in this study for the behaviors contained in the Inducing
subscale.  An alternative assessment of validity would include establishing evidence
of treatment utility of the M&M by demonstrating the connection between M&M
results and a beneficial treatment outcome (Hayes, Nelson, & Jarrett, 1987).  Another
possible assessment of validity would include comparison of scores of the M&M to
results of a more traditional behavioral assessment utilizing repeated observations and
documentation of antecedent and consequence conditions.  However, these
investigations would depend on established reliability of the M&M subscales or
individual items used in the comparison.
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Conclusions
The utility of a multifaceted approach to treatment of a variety of physical and
mental health problems has been well documented.  The present effort attempted to
take the first steps in establishing a checklist measure designed to facilitate
behavioral treatments for seizures in persons with mental retardation.  Results
revealed good reliability between graduate student scorers for nearly all items and
subscales.  However, direct care staff had an overall difficult time reporting reliable
answers to M&M questions.  Several individual items did show evidence of either
cross-rater or test-retest reliability, but very few were rated reliably both between
informants and over time.  A plausible explanation for low cross-rater and test-retest
reliability coefficients is that direct care staff need assistance or prompting to observe
events surrounding seizure occurrence; it is not sufficient to ask them to recall such
events from memory only.  This could be influenced by infrequent occurrence of
events measured by the M&M, subtle presentation when they do occur, or both.  As
such, future research will focus on methods of enhancing reliability of responding,
including education about a behavioral treatment of seizures and concurrent use of
methods to enhance memory and recognition of events (e.g., ABC log). 
Once acceptable reliability is established, further analyses of validity can
proceed.  Examination of construct validity conducted in this study provided limited
information about base rates of seizure-inducing variables, but did not provide a
comparative analysis of the discriminative properties of the M&M as a functional
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assessment measure.  This can be achieved within the context of a treatment utility or
concurrent validity study as outlined in the discussion.  
This study, while falling short of expected results, did illuminate obstacles to
overcome in developing a systematic approach to behavioral treatment of seizures in
persons with mental retardation.  Additionally, it was demonstrated that a number of
individual items can be rated reliably in one context. A limited sample of persons
with mental retardation and a seizure disorder was represented here; future studies
will broaden the sample to different levels of impairment and seizure type to
investigate the influence of these factors on consistent responding.  Given the partial
success found here, as well as the novelty and potential clinical importance of this
assessment approach, further research investigating the psychometric properties and
clinical impact of this scale is warranted.          
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Script for Informant Recruitment for Seizure Groups
Hello, my name is ________________, and I work in the department of
psychology here at Pinecrest.  I would like to talk to you briefly about     (client)    , if
you have a moment.  Specifically, I would like to ask you about his/her seizure
activity.  How many seizures would you say you have seen over the past year,
approximately?  (IF TWO OR MORE) - OK, is there somewhere here where we can
talk for about 10 to 15 minutes?  Thank you.  I am going to read some statements to
you, and I would like you to answer how often each of the behaviors described occurs
in relation to seizures.  You have three options: never occurs, sometimes occurs,
or always occurs.  Also, please state how long each of these behaviors has been
occurring in relation to seizures: less than one month, one to twelve months, or
longer than twelve months. 
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Appendix B
Script for Informant Recruitment for Validity Control Group
Hello, my name is ________________, and I work in the department of
psychology here at Pinecrest.  I would like to talk to you briefly about     (client)    , if
you have a moment.  Specifically, I would like to ask you about a number of
behaviors you may or may not have seen recently.  Is this OK?  Is there somewhere
here where we can talk for about 10 to 15 minutes?  Thank you.  I am going to read
some statements to you, and I would like you to answer how often each of the
behaviors described occurs.  You have three options: never occurs, sometimes
occurs, or always occurs.  Also, please state how long each of these behaviors has
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